Paul J Clancy Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul J Clancy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul J Clancy. Paul J Clancy is Director in INCYTE CORP ($INCY) and EVP, Chief Financial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and CFO in BIOGEN INC. ($IDPH) and Executive VP and CFO in BIOGEN INC. ($IDPH) and Director in EXACT SCIENCES CORP ($EXAS) and Director in AGIOS PHARMACEUTICALS INC ($AGIO).
Paul J Clancy in ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul J Clancy: EVP, Chief Financial Officer
Holdings: 90,447 shares
Current Value: $11,551,891
Latest Transaction: Jul 15 2019
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul J Clancy in ALEXION PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, ALXN, IDPH, EXAS, INCY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15 2019 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Payment of Exercise | F | 124.20 | 5,230 | 649,566 | 90,447 | 95.7 K to 90.4 K (-5.47 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Grant | A | 0.00 | 9,428 | 0 | 95,677 | 86.2 K to 95.7 K (+10.93 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Payment of Exercise | F | 132.93 | 1,079 | 143,431 | 86,249 | 87.3 K to 86.2 K (-1.24 %) |
| Feb 11 2019 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Payment of Exercise | F | 119.57 | 5,981 | 715,148 | 87,328 | 93.3 K to 87.3 K (-6.41 %) |
| Jul 12 2018 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Sell | S | 131.11 | 5,241 | 687,148 | 93,309 | 98.6 K to 93.3 K (-5.32 %) |
| Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Sell | S | 116.31 | 6,079 | 707,048 | 89,014 | 95.1 K to 89 K (-6.39 %) |
| Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Grant | A | 0.00 | 48,228 | 0 | 95,093 | 46.9 K to 95.1 K (+102.91 %) |
| Jul 12 2017 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Option Exercise | A | 123.76 | 29,089 | 3,600,055 | 29,089 | |
| Jul 12 2017 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Grant | A | 0.00 | 46,865 | 0 | 46,865 | 0 to 46.9 K |
Page: 1